• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲硫氨酸脑啡肽对体外伴刀豆球蛋白A诱导的淋巴细胞增殖不同阶段的免疫调节作用。

Immunomodulating effect of met-enkephalin on different stages of lymphocyte proliferation induced with concanavalin A in vitro.

作者信息

Dubinin K V, Zakharova L A, Khegai L A, Zaitsev S V

机构信息

Division of Chemical Enzymology, Lomonosov Moscow State University, Russia.

出版信息

Immunopharmacol Immunotoxicol. 1994 Aug;16(3):463-72. doi: 10.3109/08923979409007105.

DOI:10.3109/08923979409007105
PMID:7798596
Abstract

Met-enkephalin (ME) in the range of concentrations 10(-15) M to 10(-9) M has exhibited an immunomodulating effect on concanavalin A (Con A) induced proliferation of mice lymphocytes from lymph nodes in vitro. The effect of ME was shown to vary with the stage of lymphocyte activation and to depend on the mitogen dose. In the case that ME and Con A were injected simultaneously, at the zero time of proliferation, maximum inhibition was observed on the first and fourth days. In an other set of experiments when ME was added at intervals of 4 hours before measuring the proliferation response value, both inhibition (after 24 hours of proliferation) and stimulation (after 28 and 96 hours) were observed. Opioid ligands of various classes were found to act in the same manner as ME. Naloxone was shown to block the immunomodulating effect of opioids.

摘要

浓度在10⁻¹⁵ M至10⁻⁹ M范围内的甲硫氨酸脑啡肽(ME)对体外伴刀豆球蛋白A(Con A)诱导的小鼠淋巴结淋巴细胞增殖具有免疫调节作用。结果表明,ME的作用随淋巴细胞激活阶段的不同而变化,并取决于促有丝分裂原剂量。在ME和Con A同时注射的情况下,即在增殖的零时间,在第一天和第四天观察到最大抑制作用。在另一组实验中,当在测量增殖反应值前每隔4小时添加ME时,观察到了抑制作用(增殖24小时后)和刺激作用(增殖28小时和96小时后)。发现各类阿片样物质配体的作用方式与ME相同。已证明纳洛酮可阻断阿片类药物的免疫调节作用。

相似文献

1
Immunomodulating effect of met-enkephalin on different stages of lymphocyte proliferation induced with concanavalin A in vitro.甲硫氨酸脑啡肽对体外伴刀豆球蛋白A诱导的淋巴细胞增殖不同阶段的免疫调节作用。
Immunopharmacol Immunotoxicol. 1994 Aug;16(3):463-72. doi: 10.3109/08923979409007105.
2
[Factors, mediating the immunomodulating effect of met-enkephalin: effect of mitogen dose, stage of cellular activation, and time of opioid introduction].[介导甲硫氨酸脑啡肽免疫调节作用的因素:丝裂原剂量、细胞激活阶段及阿片类药物引入时间的影响]
Biull Eksp Biol Med. 1995 Apr;119(4):398-401.
3
Enhancement of T lymphocyte proliferation and suppression of antibody producing cell formation by methionine-enkephalin.甲硫氨酸脑啡肽增强T淋巴细胞增殖并抑制抗体产生细胞形成。
Zhongguo Yao Li Xue Bao. 1990 Jul;11(4):355-9.
4
Involvement of opioid receptors in Met-enkephalin modulation of blast-transformation of mouse splenocytes.阿片受体参与甲硫氨酸脑啡肽对小鼠脾细胞增殖转化的调节作用。
Immunol Lett. 1992 Mar;32(1):27-30. doi: 10.1016/0165-2478(92)90194-s.
5
Opioid agonist modulation of cytoplasmic free Ca2+ level in concanavalin A-stimulated mouse lymphocytes.阿片类激动剂对伴刀豆球蛋白A刺激的小鼠淋巴细胞胞质游离钙离子水平的调节作用
Biochemistry (Mosc). 1999 May;64(5):546-51.
6
Met-enkephalin-containing peptides encoded by proenkephalin A mRNA expressed in activated murine thymocytes inhibit thymocyte proliferation.在活化的小鼠胸腺细胞中由前脑啡肽A信使核糖核酸编码的含甲硫氨酸脑啡肽的肽类可抑制胸腺细胞增殖。
J Immunol. 1995 May 15;154(10):5049-60.
7
Suppression of T lymphocyte chemotactic factor production by the opioid peptides beta-endorphin and met-enkephalin.阿片肽β-内啡肽和甲硫氨酸脑啡肽对T淋巴细胞趋化因子产生的抑制作用。
J Immunol. 1985 May;134(5):3384-90.
8
[The effect of the stimulation of opioid receptors on lymphocyte functional activity in vivo].[阿片受体刺激对体内淋巴细胞功能活性的影响]
Biull Eksp Biol Med. 1989 Sep;108(9):315-6.
9
Effects of met-enkephalin on cell proliferation in different models of adrenocortical-cell growth.甲硫氨酸脑啡肽对不同肾上腺皮质细胞生长模型中细胞增殖的影响。
Int J Mol Med. 2005 May;15(5):841-5.
10
Methionine-enkephalin alteration of mitogenic and mixed lymphocyte culture responses in zinc-deficient mice.蛋氨酸脑啡肽对缺锌小鼠有丝分裂和混合淋巴细胞培养反应的影响
Zhongguo Yao Li Xue Bao. 1989 May;10(3):216-21.